Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Endosc. Mar 16, 2025; 17(3): 99540
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.99540
Figure 3
Figure 3 A subgroup analyses forest plot of the risk factors for metabolic dysfunction-associated steatotic liver disease associated with metachronous gastric cancer. MASLD: Metabolic dysfunction-associated steatotic liver disease; PD: Poorly differentiated; WD: Well differentiated; MD: Moderately differentiated; HR: Hazard ratio; CI: Confidence interval; H. pylori: Helicobacter pylori.